• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者对化疗恐惧的多变性:对姑息治疗的启示

The changeable nature of patients' fears regarding chemotherapy: implications for palliative care.

作者信息

Passik S D, Kirsh K L, Rosenfeld B, McDonald M V, Theobald D E

机构信息

Oncology Symptom Control Research, Indianapolis, IN 46202, USA.

出版信息

J Pain Symptom Manage. 2001 Feb;21(2):113-20. doi: 10.1016/s0885-3924(00)00249-9.

DOI:10.1016/s0885-3924(00)00249-9
PMID:11226762
Abstract

The side effects of chemotherapy are feared by cancer patients as they begin their treatment. In this study, we investigated patients' anticipatory fears about chemotherapy. We then re-assessed these fears three to six months after the initial interview for patients who received chemotherapy during that time. We also examined symptom distress at these intervals. Hair loss, vomiting, infection, nausea, and weight loss were ranked as the most feared side effects of cancer treatment for the group as they began treatment. Patients beginning chemotherapy endorsed frequent or intense levels of fatigue, worrying about the future, pain, and sleep problems. No differences were found in the reporting of symptoms based on gender, age, or educational level. While changes in symptom distress over the study period were unremarkable, changes in fears about chemotherapy were of interest. The most feared symptoms were re-ordered following the treatment experience. The endorsement of nausea and vomiting, alopecia, and loss of appetite decreased significantly. Thirty-five percent fewer chemotherapy patients reported vomiting as one of their most feared side effects; 45% fewer patients who received anti-emetics reported vomiting as one of their most feared side effects. Effective treatments, such as those that have been developed to treat acute chemotherapy-related emesis, can relieve the fears of patients on treatment. We conclude that patients' fears about treatment are fluid and malleable. Patients' fears of suffering related to chemotherapy treatment change in response to the provision of adequate management. We discuss the implications of these findings for palliative care education.

摘要

癌症患者在开始化疗时会害怕化疗的副作用。在本研究中,我们调查了患者对化疗的预期恐惧。然后,对于在此期间接受化疗的患者,我们在初次访谈后的三到六个月重新评估了这些恐惧。我们还在这些时间间隔检查了症状困扰情况。脱发、呕吐、感染、恶心和体重减轻被列为该组患者开始治疗时最害怕的癌症治疗副作用。开始化疗的患者认可频繁或强烈程度的疲劳、对未来的担忧、疼痛和睡眠问题。在基于性别、年龄或教育水平的症状报告方面未发现差异。虽然在研究期间症状困扰的变化不明显,但对化疗的恐惧变化却令人感兴趣。在经历治疗后,最害怕的症状顺序发生了重新排列。对恶心和呕吐、脱发以及食欲不振的认可显著下降。报告呕吐是其最害怕副作用之一的化疗患者减少了35%;接受止吐药治疗的患者中,报告呕吐是其最害怕副作用之一的患者减少了45%。有效的治疗方法,如已开发用于治疗急性化疗相关呕吐的方法,可以减轻正在接受治疗的患者的恐惧。我们得出结论,患者对治疗的恐惧是可变且可塑的。患者对与化疗治疗相关痛苦的恐惧会随着提供充分的管理而改变。我们讨论了这些发现对姑息治疗教育的意义。

相似文献

1
The changeable nature of patients' fears regarding chemotherapy: implications for palliative care.患者对化疗恐惧的多变性:对姑息治疗的启示
J Pain Symptom Manage. 2001 Feb;21(2):113-20. doi: 10.1016/s0885-3924(00)00249-9.
2
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.在癌症患者中,接受中度致吐性化疗或蒽环类和环磷酰胺方案后,使用罗哌司他预防化疗引起的恶心和呕吐的安全性和疗效:一项随机、活性对照、双盲、3 期临床试验。
Lancet Oncol. 2015 Sep;16(9):1071-1078. doi: 10.1016/S1470-2045(15)00034-0. Epub 2015 Aug 10.
3
Does assessing patients' expectancies about chemotherapy side effects influence their occurrence?评估患者对化疗副作用的预期是否会影响其发生?
J Pain Symptom Manage. 2013 Aug;46(2):275-81. doi: 10.1016/j.jpainsymman.2012.07.013. Epub 2012 Nov 11.
4
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
5
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.在癌症患者中,顺铂类高度致吐性化疗后使用罗哌司他预防化疗引起的恶心和呕吐的安全性和疗效:两项随机、阳性对照、双盲、3 期临床试验。
Lancet Oncol. 2015 Sep;16(9):1079-1089. doi: 10.1016/S1470-2045(15)00035-2. Epub 2015 Aug 10.
6
Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life.姑息化疗期间的症状群及其对功能和生活质量的影响。
Support Care Cancer. 2017 May;25(5):1519-1527. doi: 10.1007/s00520-016-3545-z. Epub 2016 Dec 28.
7
Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients.化疗患者预期性恶心和呕吐的患病率及其相关因素
J Natl Cancer Inst. 1982 Apr;68(4):585-8.
8
Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms.化疗后患者的体验与临床医生对症状(化疗引起的恶心呕吐及伴随症状)的认知之间存在差距。
Support Care Cancer. 2016 Nov;24(11):4559-66. doi: 10.1007/s00520-016-3295-y. Epub 2016 Jun 8.
9
Effect on symptom control of structured information given to patients receiving chemotherapy.给予接受化疗患者结构化信息对症状控制的影响。
Eur J Oncol Nurs. 2014 Feb;18(1):78-84. doi: 10.1016/j.ejon.2013.07.006. Epub 2013 Oct 4.
10
Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy.催眠疗法对接受癌症化疗患者预期性恶心和呕吐的治疗作用
Oncology. 2000 Aug;59(2):100-4. doi: 10.1159/000012144.

引用本文的文献

1
The power of phages: revolutionizing cancer treatment.噬菌体的力量:革新癌症治疗
Front Oncol. 2023 Nov 15;13:1290296. doi: 10.3389/fonc.2023.1290296. eCollection 2023.
2
Experiences of participants in a clinical trial of a novel radioactive treatment for advanced prostate cancer: A nested, qualitative longitudinal study.一种新型放射性治疗晚期前列腺癌的临床试验中参与者的体验:一项嵌套式、定性纵向研究。
PLoS One. 2022 Nov 9;17(11):e0276063. doi: 10.1371/journal.pone.0276063. eCollection 2022.
3
Distress and Spiritual Well-Being in Brazilian Patients Initiating Chemotherapy during the COVID-19 Pandemic-A Cross-Sectional Study.
巴西患者在 COVID-19 大流行期间开始化疗时的痛苦和精神健康状况:一项横断面研究。
Int J Environ Res Public Health. 2021 Dec 15;18(24):13200. doi: 10.3390/ijerph182413200.
4
Metagenomics and chemotherapy-induced nausea: A roadmap for future research.宏基因组学与化疗所致恶心:未来研究的路线图。
Cancer. 2022 Feb 1;128(3):461-470. doi: 10.1002/cncr.33892. Epub 2021 Oct 13.
5
Real-world emetic risk of chemotherapy and the corresponding antiemetic therapy in Japan: A study based on a nationwide database.日本真实世界化疗致吐风险及相应止吐治疗的研究:基于全国性数据库的研究。
Cancer Rep (Hoboken). 2022 Mar;5(3):e1482. doi: 10.1002/cnr2.1482. Epub 2021 Jun 27.
6
Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.裸盖菇素作为在危及生命疾病背景下治疗抑郁症和焦虑症的新方法——临床试验的系统评价与荟萃分析
Biomedicines. 2020 Sep 5;8(9):331. doi: 10.3390/biomedicines8090331.
7
Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting: An updated systematic review and meta-analysis.阿瑞匹坦用于预防化疗引起的恶心和呕吐的止吐方案:一项更新的系统评价和荟萃分析。
Medicine (Baltimore). 2020 Aug 14;99(33):e21559. doi: 10.1097/MD.0000000000021559.
8
The Fear of Cancer from the Standpoint of Oneself, the Opposite Sex and the Fear of Side Effects of Cancer Treatment.从自身、异性角度看对癌症的恐惧以及对癌症治疗副作用的恐惧
Cancer Res Treat. 2020 Oct;52(4):993-1001. doi: 10.4143/crt.2020.285. Epub 2020 Jun 24.
9
Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience.奈妥匹坦/帕洛诺司琼与地塞米松联合用于接受帕洛诺司琼和地塞米松预防化疗引起的恶心和呕吐效果欠佳的经典型霍奇金淋巴瘤患者的安全性和有效性:单中心真实世界经验
Int J Hematol Oncol. 2020 Feb 28;9(1):IJH23. doi: 10.2217/ijh-2020-0001.
10
Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective.化疗引起的恶心和呕吐有效管理专家共识:印度视角
Front Oncol. 2020 Mar 27;10:400. doi: 10.3389/fonc.2020.00400. eCollection 2020.